Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Microbial Identification Market By Products & Services, By Method, By Application, By End User, and Geography
Microbial Identification Market By Products & Services, By Method, By Application, By End User, and Geography
Microbial Identification Market size was valued at US$ 2.3 billion in 2023 and is poised to grow at a CAGR of 6.2% from 2024-2030. The microbial identification market is projected to hit US$ 3.8 billion by 2028. The growth of the market is mainly driven by the growing occurrence of infectious diseases, combined with influenza and pandemic outbreaks, rising concerns about food safety, technical developments in microbial identification techniques, and government initiatives and funding to encourage microbial identification. However, high cost of the equipment hinders the market. In 2015, Charles River laboratories have acquired Celsis International Ltd. for $212 million US$ to improve its product portfolio.
This market report provides a comprehensive outlook on worldwide with a specific focus on the key regions such as North America, Europe, Asia Pacific, Latin America, and MEA. This report gives historical, current, and future market size (US$ Mn) on the basis of product & services, method, application, end user, and geography. This study analyses the global market dynamics in a detailed manner to identify current trends and drivers, growth opportunities and potential challenges to the key stakeholders in the operating market. In addition, PBI has analyzed the global market to better equip customers with possible investment opportunities across region and consumer unmet needs. This report considers the influence of COVID-19 on the market and includes insights, analysis, projections, and predictions.
Study Period
2024-2030Base Year
2023CAGR
6.2%Largest Market
North AmericaFastest Growing Market
Asia Pacific
One of the critical factors that will drive microbial identification market growth is the increasing demand for food safety testing. During production, microbes from natural sources contaminate the food, contributing to food spoilage and food borne illnesses. With increasing cases of food borne diseases, food safety testing is becoming increasingly relevant. Governments in many countries have also begun to concentrate on the implementation of food safety regulations and are tracking the efficacy of control measures to eliminate food borne diseases. The need for these goods and services to restrict these items would then be motivated by this. During the forecast period, these trends would increase the global market size for microbial identification.
North America has a good hold on the new innovations available on the market due to numerous technological developments that drive the growth of the market. Moreover, the existence of major players suggests a high availability of microbial identification-related products. However, several microbial identification products in the United States have yet to be approved. This is hindering the development of the region demand for microbial identification.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 2.3 billion |
|
Market Size in 2028 |
US$ 3.8 billion |
|
Market CAGR |
6.2% |
|
By Products & Services |
|
|
By Method |
|
|
By Application |
|
|
By End User |
|
Download Free Sample Report
The global microbial identification market size was valued at US$ 2.3 billion in 2023 and is expected to grow at a CAGR of 6.2% from 2024 to 2030.
Becton, Dickinson & Company, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Bruker Corporation, Shimadzu Corporation
Government initiatives and funding for Promoting Microbial Identification
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.